These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 22915134)

  • 1. Anti-high mobility group box-1 antibody therapy for traumatic brain injury.
    Okuma Y; Liu K; Wake H; Zhang J; Maruo T; Date I; Yoshino T; Ohtsuka A; Otani N; Tomura S; Shima K; Yamamoto Y; Yamamoto H; Takahashi HK; Mori S; Nishibori M
    Ann Neurol; 2012 Sep; 72(3):373-84. PubMed ID: 22915134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycyrrhizin inhibits traumatic brain injury by reducing HMGB1-RAGE interaction.
    Okuma Y; Liu K; Wake H; Liu R; Nishimura Y; Hui Z; Teshigawara K; Haruma J; Yamamoto Y; Yamamoto H; Date I; Takahashi HK; Mori S; Nishibori M
    Neuropharmacology; 2014 Oct; 85():18-26. PubMed ID: 24859607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simvastatin reduces secondary brain injury caused by cortical contusion in rats: possible involvement of TLR4/NF-kappaB pathway.
    Chen G; Zhang S; Shi J; Ai J; Qi M; Hang C
    Exp Neurol; 2009 Apr; 216(2):398-406. PubMed ID: 19166837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-high mobility group box-1 monoclonal antibody protects the blood-brain barrier from ischemia-induced disruption in rats.
    Zhang J; Takahashi HK; Liu K; Wake H; Liu R; Maruo T; Date I; Yoshino T; Ohtsuka A; Mori S; Nishibori M
    Stroke; 2011 May; 42(5):1420-8. PubMed ID: 21474801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High mobility group box 1 promotes small intestinal damage induced by nonsteroidal anti-inflammatory drugs through Toll-like receptor 4.
    Nadatani Y; Watanabe T; Tanigawa T; Machida H; Okazaki H; Yamagami H; Watanabe K; Tominaga K; Fujiwara Y; Arakawa T
    Am J Pathol; 2012 Jul; 181(1):98-110. PubMed ID: 22634181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic involvement of high-mobility group box 1 protein and therapeutic effect of anti-high-mobility group box 1 protein antibody in a rat model of crush injury.
    Shimazaki J; Matsumoto N; Ogura H; Muroya T; Kuwagata Y; Nakagawa J; Yamakawa K; Hosotsubo H; Imamura Y; Shimazu T
    Shock; 2012 Jun; 37(6):634-8. PubMed ID: 22392147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of glycyrrhizin on traumatic brain injury in rats and its mechanism.
    Gu XJ; Xu J; Ma BY; Chen G; Gu PY; Wei D; Hu WX
    Chin J Traumatol; 2014; 17(1):1-7. PubMed ID: 24506915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor for Advanced Glycation Endproducts is upregulated in temporal lobe epilepsy and contributes to experimental seizures.
    Iori V; Maroso M; Rizzi M; Iyer AM; Vertemara R; Carli M; Agresti A; Antonelli A; Bianchi ME; Aronica E; Ravizza T; Vezzani A
    Neurobiol Dis; 2013 Oct; 58():102-14. PubMed ID: 23523633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats.
    Liu K; Mori S; Takahashi HK; Tomono Y; Wake H; Kanke T; Sato Y; Hiraga N; Adachi N; Yoshino T; Nishibori M
    FASEB J; 2007 Dec; 21(14):3904-16. PubMed ID: 17628015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMGB1 a-Box Reverses Brain Edema and Deterioration of Neurological Function in a Traumatic Brain Injury Mouse Model.
    Yang L; Wang F; Yang L; Yuan Y; Chen Y; Zhang G; Fan Z
    Cell Physiol Biochem; 2018; 46(6):2532-2542. PubMed ID: 29742510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-High Mobility Group Box 1 Antibody Therapy May Prevent Cognitive Dysfunction After Traumatic Brain Injury.
    Okuma Y; Wake H; Teshigawara K; Takahashi Y; Hishikawa T; Yasuhara T; Mori S; Takahashi HK; Date I; Nishibori M
    World Neurosurg; 2019 Feb; 122():e864-e871. PubMed ID: 30391757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-high mobility group box-1 (HMGB1) antibody inhibits hemorrhage-induced brain injury and improved neurological deficits in rats.
    Wang D; Liu K; Wake H; Teshigawara K; Mori S; Nishibori M
    Sci Rep; 2017 Apr; 7():46243. PubMed ID: 28393932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-mobility group box 1 inhibits HCO(3)(-) absorption in medullary thick ascending limb through a basolateral receptor for advanced glycation end products pathway.
    Good DW; George T; Watts BA
    Am J Physiol Renal Physiol; 2015 Oct; 309(8):F720-30. PubMed ID: 26180239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omega-3 polyunsaturated fatty acid supplementation attenuates microglial-induced inflammation by inhibiting the HMGB1/TLR4/NF-κB pathway following experimental traumatic brain injury.
    Chen X; Wu S; Chen C; Xie B; Fang Z; Hu W; Chen J; Fu H; He H
    J Neuroinflammation; 2017 Jul; 14(1):143. PubMed ID: 28738820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-high mobility group box-1 antibody therapy for traumatic brain injury].
    Okuma Y; Date I; Nishibori M
    Yakugaku Zasshi; 2014; 134(6):701-5. PubMed ID: 24882644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does enoxaparin interfere with HMGB1 signaling after TBI? A potential mechanism for reduced cerebral edema and neurologic recovery.
    Li S; Eisenstadt R; Kumasaka K; Johnson VE; Marks J; Nagata K; Browne KD; Smith DH; Pascual JL
    J Trauma Acute Care Surg; 2016 Mar; 80(3):381-7; discussion 387-9. PubMed ID: 26670109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-mobility-group box protein 1A box reduces development of sodium laurate-induced thromboangiitis obliterans in rats.
    Kong X; Yuan H; Wu X; Zhang J; Zhou H; Wang M; Liu Y; Jin X
    J Vasc Surg; 2013 Jan; 57(1):194-204. PubMed ID: 23069071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-mobility group box-1 in ischemia-reperfusion injury of the heart.
    Andrassy M; Volz HC; Igwe JC; Funke B; Eichberger SN; Kaya Z; Buss S; Autschbach F; Pleger ST; Lukic IK; Bea F; Hardt SE; Humpert PM; Bianchi ME; Mairbäurl H; Nawroth PP; Remppis A; Katus HA; Bierhaus A
    Circulation; 2008 Jun; 117(25):3216-26. PubMed ID: 18574060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of lycopene on HMGB1-mediated pro-inflammatory responses in both cellular and animal models.
    Lee W; Ku SK; Bae JW; Bae JS
    Food Chem Toxicol; 2012 Jun; 50(6):1826-33. PubMed ID: 22429818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-high mobility group box 1 antibody exerts neuroprotection in a rat model of Parkinson's disease.
    Sasaki T; Liu K; Agari T; Yasuhara T; Morimoto J; Okazaki M; Takeuchi H; Toyoshima A; Sasada S; Shinko A; Kondo A; Kameda M; Miyazaki I; Asanuma M; Borlongan CV; Nishibori M; Date I
    Exp Neurol; 2016 Jan; 275 Pt 1():220-31. PubMed ID: 26555088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.